Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELOXATIN for Rectal cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where ELOXATIN was used for Rectal cancer.

Most Reported Side Effects for ELOXATIN

Side Effect Reports % Deaths Hosp.
Nausea 14 12.7% 2 8
Vomiting 11 10.0% 1 7
Diarrhoea 10 9.1% 2 7
Abdominal pain 8 7.3% 0 8
Chills 8 7.3% 1 3
Dyspnoea 7 6.4% 2 1
Febrile neutropenia 7 6.4% 1 6
Neuropathy peripheral 7 6.4% 0 0
Paraesthesia 7 6.4% 0 1
Pyrexia 7 6.4% 0 4
Anaemia 6 5.5% 2 5
Erythema 6 5.5% 0 1
Blood pressure increased 5 4.6% 0 0
Death 5 4.6% 5 0
Embolism 5 4.6% 0 5

Other Indications for ELOXATIN

Colon cancer (20) Adenocarcinoma of colon (16) Product used for unknown indication (8) Pancreatic carcinoma (7)

Other Drugs Used for Rectal cancer

CAPECITABINE (2,976) OXALIPLATIN (2,402) FLUOROURACIL (1,610) BEVACIZUMAB (1,546) TIPIRACIL\TRIFLURIDINE (1,297) IRINOTECAN (985) LEUCOVORIN (660) CETUXIMAB (542) REGORAFENIB (505) PANITUMUMAB (374)

Related Pages

ELOXATIN Full Profile All Rectal cancer Drugs ELOXATIN Demographics ELOXATIN Timeline